How to optimize colon cancer surveillance in inflammatory bowel disease patients

Inflammatory Bowel Diseases

Volumn 22, Issue 5, 2016, Pages 1219-1230

  Gaidos, Jill K J ^a   Bickston, Stephen J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

chromoendoscopy; colorectal cancer; colorectal neoplasia; Crohn's disease; ulcerative colitis

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CHROMOENDOSCOPY; COLON CANCER; CONFOCAL LASER MICROSCOPY; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FLUORESCENCE IMAGING; HUMAN; ILEITIS; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; NARROW BAND IMAGING; POLYP; PRACTICE GUIDELINE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PSEUDOPOLYP; REVIEW; RISK FACTOR; WHITE LIGHT ENDOSCOPY; COLONIC NEOPLASMS; COMPLICATION; EARLY CANCER DIAGNOSIS; HEALTH SURVEY; STANDARDS;

COLONIC NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; INFLAMMATORY BOWEL DISEASES; POPULATION SURVEILLANCE;

EID: 84964893073     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000685     Document Type: Review

References (91)

1. Crohn BB, Rosenburg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci. 1925; 170: 220-227
2. Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003; 18 (suppl 2): 1-5
3. Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010; 101: 706-712
4. Herrinton LJ, Liu L, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012; 143: 382-389
5. Askling J, Dickman PW, Karlén P, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001; 120: 1356-1362
6. Collins PD, Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006: CD000279
7. Choi PM, Nugent FW, Schoetz DJ Jr, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993; 105: 418-424
8. Lutgens MW, Oldenberg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009; 101: 1671-1675
9. Ananthakrishnan AN, Cagan A, Cai T, et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015; 13: 322-329
10. Howlader N, Noore AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute. Available at: http://www.cdc.gov/cancer/colorectal/statistics/age.htm. Accessed August 28, 2015
11. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-Analysis. Gut. 2001; 48: 526-535
12. Canavan C, Abrams KR, Mayberry J. Meta-Analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006; 23: 1097-1104
13. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet. 1990; 336: 357-359
14. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001; 91: 854-862
15. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006; 130: 1030-1038
16. Jess T, Simonsen J, Jørgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology. 2012; 143: 375-381
17. Söderlund S, Brandt L, Lapidus A, et al. Decreasing time-Trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology. 2009; 136: 1561-1567
18. Desai D, Shah S, Deshmukh A, et al. Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer. World J Gastroenterol. 2015; 21: 3644-3649
19. Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitisassociated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011; 17: 802-808
20. Choi CH, Rutter MD, Askari A, et al. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol. 2015; 110: 1022-1034
21. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-Analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012; 10: 639-645
22. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Eng J Med. 1990; 323: 1228-1233
23. Rubin DT, Huo D, Kinnucan JA, et al. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a casecontrol study. Clin Gastroenterol Hepatol. 2013; 11: 1601-1608
24. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004; 126: 451-459
25. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007; 133: 1099-1105
26. Velayos FS, Loftus EV Jr, Jess T, et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006; 130: 1941-1949
27. Rutter MD, Saunders B, Wilkinson KH, et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut. 2004; 53: 1813-1816
28. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-Analysis. Gastrointest Endosc. 2002; 56: 48-54
29. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006; 130: 1039-1046
30. Winther KV, Jess T, Langholz E, et al. Long-Term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004; 2: 1088-1095
31. Kim BJ, Yang SK, Kim JS, et al. Trends in ulcerative colitis-Associated colorectal cancer in Korea: a KASID study. J Gastroenterol Hepatol. 2009; 24: 667-671
32. Mayer R, Wong WD, Rothenberger DA, et al. Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum. 1999; 42: 343-347
33. Pinczowski D, Ekbom A, Baron J, et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology. 1994; 107: 117-120
34. Karlén P, Löfberg R, Broström O, et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 1999; 94: 1047-1052
35. Weedon DD, Shorter RG, Ilstrup DM, et al. Crohn's disease and cancer. N Eng J Med. 1973; 289: 1099-1103
36. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal risk in extensive colitis. Gut. 1994; 35: 1590-1592
37. Markowitz J, McKinley M, Kahn E, et al. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis. Am J Gastroenterol. 1997; 92: 2001-2006
38. Mathy C, Schneider K, Chen YY, et al. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis. Inflamm Bowel Dis. 2003; 9: 351-355
39. Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001; 120: 841-847
40. Haskell H, Andrews CW Jr, Reddy SI, et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005; 29: 1472-1481
41. Broomé U, Löfberg R, Veress B, et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology. 1995; 22: 1404-1408
42. Higashi H, Yanaga K, Marsh JW, et al. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology. 1990; 11: 477-480
43. Bleday R, Lee E, Jessurun J, et al. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum. 1993; 36: 908-912
44. Vera A, Gunson BK, Ussatoff V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation. 2003; 75: 1983-1988
45. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology. 1998; 115: 1079-1083
46. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010; 59: 666-690
47. Party CCACSW, ed. Clinical Practice Guidelines for Surveillance Colonoscopy-in Adenoma Follow-up: Following Curative Resection of Colorectal Cancer; and for Cancer Surveillance in Inflammatory Bowel Disease. Sydney, Australia: Cancer Council of Australia; 2011
48. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2012; 7: 1-33
49. Shergill AK, Lightdale JR, Bruining DH, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015; 81: 1101-1121
50. Annese V, Daperno M, Rutter MD, et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis. 2013; 7: 982-1018
51. Howdle P, Atkin W, Rutter M. Colonoscopic Surveillance for Prevention of Colorectal Cancer in People with Ulcerative Colitis, Crohn's Disease or Adenomas. National Institute for Health and Clinical Excellence (NICE) Clinical guideline 118. London, United Kingdom: National Institute for Health and Clinical Excellence; 2011
52. Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010; 138: 746-774
53. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010; 105: 501-523
54. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 314-321
55. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Eng J Med. 2015; 372: 1441-1452
56. Rubin DT, Rothe JA, Hetzel JT, et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis'. Gastrointest Endosc. 2007; 65: 998-1004
57. Wang YR, Cangemi JR, Loftus EV, et al. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol. 2013; 108: 444-449
58. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992; 103: 1611-1620
59. East JE. Colonoscopic cancer surveillance in inflammatory bowel disease: what's new beyond random biopsy'. Clin Endosc. 2012; 45: 274-277
60. Van Den Broek FJ, Stokkers PC, Reitsma JB, et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol. 2014; 109: 715-722
61. Navaneethan U, Kochhar G, Vankatesh PGK, et al. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis. Inflamm Bowel Dis. 2013; 7: 974-981
62. Van Rijn AF, Fockens P, Siersema PD, et al. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol. 2009; 15: 226-230
63. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc. 2000; 51: 123-128
64. Subramanian V, Ramappa V, Telakis E, et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis. 2013; 19: 350-355
65. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-Aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003; 124: 880-888
66. Matsumoto T, Nakamura S, Jo Y, et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol. 2003; 98: 1827-1833
67. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004; 53: 256-260
68. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007; 132: 874-882
69. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-Targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008; 103: 2342-2349
70. Hlavarty T, Huorka M, Koller T, et al. Colorectal cancer screening in patients with ulcerative colitis and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy. Eur J Gastroenterol Hepatol. 2011; 23: 680-689
71. Günther U, Kusch D, Heller F, et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis. 2011; 26: 667-672
72. Picco MF, Pasha S, Leighton JA, et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy in ulcerative colitis. Inflamm Bowel Dis. 2013; 19: 1913-1920
73. Hurlstone DP, Saunders DS, Lobo AJ, et al. Indigo carmine-Assisted highmagnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy. 2005; 37: 1186-1192
74. Mooiweer E, Van Der Meulen-de Jong AE, Ponsioen CY, et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol. 2015; 110: 1014-1021
75. Subramanian V, Mannath J, Ragunath K, et al. Meta-Analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33: 304-312
76. Soetikno R, Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology. 2013; 144: 1349-1352
77. Dekker E, Van Den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy. 2007; 39: 216-221
78. Van Den Broek FJ, Fockens P, Van Eeden S, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy. 2011; 43: 108-115
79. Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol. 2012; 107: 885-890
80. Pellisé M, López-Cerón M, Rodríguez De Miguel C, et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: a prospective, randomized, crossover study. Gastrointest Endosc. 2011; 74: 840-848
81. Leifeld L, Rogler G, Stallmach A, et al. White-light or narrow-band imaging colonoscopy in surveillance of ulcerative colitis: a prospective multicenter study. Clin Gastroenterol Hepatol. 2015; 13: 1776-1781
82. Neumann H, Kiesslich R. Endomicroscopy and endocytoscopy in IBD. Gastrointest Endosc Clin N Am. 2013; 23: 695-705
83. Rispo A, Castiglione F, Staibano S, et al. Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. World J Gastroenterol Endosc. 2012; 4: 414-420
84. Messmann H, Endlicher E, Freunek G, et al. Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-Aminolaevulinic acid sensitization. Gut. 2003; 52: 1003-1007
85. Van Den Broek JF, Fockens P, Van Eeden S, et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut. 2008; 57: 1083-1089
86. Lutgens M, Vermeire S, Van Oijen M, et al. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015; 13: 148-154
87. Lutgens M, Van Oijen M, Mooiweer E, et al. A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines. Gastrointest Endosc. 2014; 80: 842-848
88. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015; 81: 489-501
89. Kaltenbach T, Soetikno R. Nonpolypoid colorectal neoplasms in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014; 24: 327-526
90. Kaltenbach T, McQuaid KR, Sanchez-Yague A, et al. Chromoendoscopy with targeted biopsy to detect nonpolypoid colorectal neoplasia in IBD. 2014. Available at: https://www.youtube.com/watch'v'OARkbgwlObI. Accessed September 15, 2015
91. Marion JF, Ullman T. Wave of the future: is chromoendoscopy becoming the standard technique for colon cancer surveillance for IBD patients'. AGA Perspect. 2015; 11: 5-9